by | Sep 14, 2023 | Publications
Genes Cancer. 2023 Jan 19;14:1-2. doi: 10.18632/genesandcancer.228. eCollection 2023. NO ABSTRACT PMID:37705996 | PMC:PMC10496929 | DOI:10.18632/genesandcancer.228
by | Sep 10, 2023 | Publications
Med Oncol. 2023 Sep 9;40(10):295. doi: 10.1007/s12032-023-02166-8. ABSTRACT Adult T-cell leukemia/lymphoma (ATLL), an infrequent malignancy resultant from human T-cell lymphotropic virus type I (HTLV-1), exhibits a spectrum of phenotypes, encompassing acute,...
by | Sep 9, 2023 | Publications
Int J Mol Sci. 2023 Aug 23;24(17):13119. doi: 10.3390/ijms241713119. ABSTRACT HTLV-1 is an oncogenic human retrovirus and the etiologic agent of the highly aggressive ATL malignancy. Two viral genes, Tax and Hbz, are individually linked to oncogenic transformation and...
by | Sep 9, 2023 | Publications
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231197592. doi: 10.1177/03946320231197592. ABSTRACT BACKGROUND: Adult T-cell leukemia/lymphoma (ATL) is a lymphoid malignancy caused by HTLV-1 infection, with distinct geographical distribution. Despite advances in...
by | Sep 8, 2023 | Publications
PLoS One. 2023 Sep 8;18(9):e0287416. doi: 10.1371/journal.pone.0287416. eCollection 2023. ABSTRACT Human T-lymphotropic virus (HTLV), a group of retroviruses belonging to the oncovirus family, has long been associated with various inflammatory and immunosuppressive...
by | Sep 5, 2023 | Publications
Sci Rep. 2023 Sep 4;13(1):14524. doi: 10.1038/s41598-023-41875-y. ABSTRACT Human T-lymphotropic virus (HTLV) infection has a worldwide distribution and currently, more than 2.5 million individuals have been infected in Brazil. The study aimed to investigate HTLV...
